Skip to main content
. Author manuscript; available in PMC: 2009 Nov 30.
Published in final edited form as: Circulation. 2006 Nov 14;114(23):2449–2457. doi: 10.1161/CIRCULATIONAHA.106.669432

Table 4.

Utilization of Medical Therapies at Discharge

Discharge
1 Year
Agent PCI (n=195) MED (n=186) PCI (n=184) MED (n=172)
Aspirin  99.0  96.8 94.6 94.2
Thienopyridine (clopidogrel or ticlopidine)  92.8    30.6* 33.1 23.3
Aspirin or thienopyridine 100.0  99.5 96.2 97.7
Aspirin plus thienopyridine  91.8    28.0* 22.3  12.8
Warfarin   8.7  16.1 NC NC
One or more of ASA, warfarin, thienopyridine 100.0 100.0
Two or more of ASA, warfarin, thienopyridine  93.3    41.9*
β-Blocker  88.7  94.1 85.3  93.6
ACE inhibitor or ARB  86.7  89.8 87.5 90.1
Spironolactone   4.1   7.5  9.2 11.0
Lipid-lowering agent  83.6  85.5 88.6 90.7

ASA indicates aspirin; NC, not collected; ACE, angiotensin-converting enzyme; and ARB, angiotensin receptor blocker. All values are percentages.

*

P<0.001 at discharge;

P<0.05 at 1 year.